Journals

Engineering 1
Frontiers of Medicine 10

Selected
Sort by
Export

Risk factors for chronic graft-versus-host disease after anti-thymocyte globulin-based haploidentical hematopoietic stem cell transplantation in acute myeloid leukemia

Meng Lv Xiaohui Zhang Lanping Xu Yu Wang Chenhua Yan Huan Chen Yuhong Chen Wei Han Fengrong Wang Jingzhi Wang Kaiyan Liu Xiaojun Huang Xiaodong Mo

acute graft-versus-host disease,chronic graft-versus-host disease,National Institutes of Health consensus criteria,acute myeloid leukemia,anti-thymocyte globulin,

Frontiers of Medicine 2019.13(6) 667-679
Positive stool culture could predict the clinical outcomes of haploidentical hematopoietic stem cell transplantation

Lijuan Hu Qi Wang Xiaohui Zhang Lanping Xu Yu Wang Chenhua Yan Huan Chen Yuhong Chen Kaiyan Liu Hui Wang Xiaojun Huang Xiaodong Mo

haploidentical,hematopoietic stem cell transplantation,stool culture,Candida,

Frontiers of Medicine 2019.13(4) 492-503
Everyone has a donor: contribution of the Chinese experience to global practice of haploidentical hematopoietic stem cell transplantation

Meng Lv Yingjun Chang Xiaojun Huang

haploidentical hematopoietic stem cell transplantation,conditioning,graft-versus-host disease,relapse,infection,donor selection,

Frontiers of Medicine 2019.13(1) 45-56
Minimal residual disease-directed immunotherapy for high-risk myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation

Xiaodong Mo Xiaohui Zhang Lanping Xu Yu Wang Chenhua Yan Huan Chen Yuhong Chen Wei Han Fengrong Wang Jingzhi Wang Kaiyan Liu Xiaojun Huang

donor leukocyte infusion,hematopoietic stem cell transplantation,interferon-
Frontiers of Medicine 2019.13(3) 354-364

Donor-Derived CD19-Targeted T Cell Infusion Eliminates B Cell Acute Lymphoblastic Leukemia Minimal Residual Disease with No Response to Donor Lymphocytes after Allogeneic Hematopoietic Stem Cell Transplantation Article

Yifei Cheng Yuhong Chen Chenhua Yan Yu Wang Xiangyu Zhao Yao Chen Wei Han Lanping Xu Xiaohui Zhang Kaiyan Liu Shasha Wang Lungji Chang Lei Xiao Xiaojun Huang

Donor-derived CD19-targeted T cell infusion, Hematopoietic stem cell transplantation, B cell acute lymphoblastic leukemia, Minimal residual disease

Engineering 2019.5(1) 150-155

Clinical risk score for invasive fungal diseases in patients with hematological malignancies undergoing chemotherapy: China Assessment of Antifungal Therapy in Hematological Diseases (CAESAR) study

Ling Wang Ying Wang Jiong Hu Yuqian Sun He Huang Jing Chen Jianyong Li Jun Ma Juan Li Yingmin Liang Jianmin Wang Yan Li Kang Yu Jianda Hu Jie Jin Chun Wang Depei Wu Yang Xiao Xiaojun Huang

invasive fungal diseases,hematological malignancies,chemotherapy,risk score,prophylaxis,

Frontiers of Medicine 2019.13(3) 365-377

Four-year follow-up of patients with imatinib-resistant or intolerant chronic myeloid leukemia receiving dasatinib: efficacy and safety

Xiaojun Huang Qian Jiang Jianda Hu Jianyong Li Jie Jin Fanyi Meng Zhixiang Shen Ting Liu Depei Wu Jianmin Wang Jianxiang Wang

chronic myeloid leukemia (CML),dasatinib,tyrosine kinase inhibitor,long-term follow-up,

Frontiers of Medicine 2019.13(3) 344-353

Interferon-α salvage treatment is effective for patients with acute leukemia/myelodysplastic syndrome with unsatisfactory response to minimal residual disease-directed donor lymphocyte infusion after allogeneic hematopoietic stem cell transplantation

Xiaodong Mo Xiaohui Zhang Lanping Xu Yu Wang Chenhua Yan Huan Chen Yuhong Chen Wei Han Fengrong Wang Jingzhi Wang Kaiyan Liu Xiaojun Huang

interferon-α,hematopoietic stem cell transplantation,minimal residual disease,donor lymphocyte infusion,

Frontiers of Medicine 2019.13(2) 238-249

Comparison of reference values for immune recovery between event-free patients receiving haploidentical allografts and those receiving human leukocyte antigen-matched sibling donor allografts

Xuying Pei Xiangyu Zhao Yu Wang Lanping Xu Xiaohui Zhang Kaiyan Liu Yingjun Chang Xiaojun Huang

immune reconstitution,hematopoietic stem cell transplantation,event-free patients,reference range,

Frontiers of Medicine 2018.12(2) 153-163

Superiority of allogeneic hematopoietic stem cell transplantation to nilotinib and dasatinib for adult patients with chronic myelogenous leukemia in the accelerated phase

Lanping Xu Huanling Zhu Jianda Hu Depei Wu Hao Jiang Qian Jiang Xiaojun Huang

chronic myeloid leukemia,imatinib,dasatinib,nilotinib,allogeneic hematopoietic stem cell transplantation

Frontiers of Medicine 2015.9(3) 304-311

Journals

Related search

Relevant information